Additionally, quercetin inhibits GC angiogenesis by downregulating vascular endothelial growth factor A (VEGF-A) and its receptor VEGFR-2 expression, and demonstrates anti-metastatic effects by modulating urokinase-type plasminogen activator (uPA) and its receptor (uPAR) function. Here, PLAUR is linked to gastric cancer.